APRIL BIO
April Bio is a drug development company that develops antibodies and long-acting biologics.
APRIL BIO
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2013-01-01
Address:
Chuncheon, Kangwon-do, South Korea
Country:
South Korea
Website Url:
http://www.aprilbio.com
Total Employee:
11+
Status:
Active
Contact:
+82 02 6956 8383
Total Funding:
53 B KRW
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apache Pound Sterling JQuery CDN Korea Telecom
Similar Organizations
Aimble
Aimble is an AI drug development company that offers drugs to treat intractable diseases.
Haihe Biopharma
Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.
ProAbTech
ProAbTech is a research and development company that develops conjugated biological drugs.
Toll Biotech
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets.
Investors List
BNK Securities
BNK Securities investment in Series C - April Bio
Hana Financial Investment
Hana Financial Investment investment in Series C - April Bio
NH Investment & Securities
NH Investment & Securities investment in Series C - April Bio
Shinhan Asset Management
Shinhan Asset Management investment in Series C - April Bio
Baro Ventures
Baro Ventures investment in Series C - April Bio
Hana Securities
Hana Securities investment in Series C - April Bio
Premier Partners
Premier Partners investment in Series C - April Bio
DS Asset Management
DS Asset Management investment in Series C - April Bio
LB Investment
LB Investment investment in Series C - April Bio
DAOL Investment & Securities
DAOL Investment & Securities investment in Series C - April Bio
Official Site Inspections
http://www.aprilbio.com
- Host name: 183.111.169.45
- IP address: 183.111.169.45
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "April Bio"
April Bio - Crunchbase Company Profile & Funding
Organization. April Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. April Bio is a drug …See details»
APRILBIO
AprilBio, APB-A1 "The composition patent granted in the U.S." AprilBio (CEO, Sang-hoon CHA) announced on the 5th of October that the compound patent of APB-A1 (Lu AG22515, CD40L …See details»
AprilBio - Products, Competitors, Financials, Employees, …
AprilBio, on the other hand, has shown strong financial performance, recording an operating profit of 13.2 billion won on a cumulative basis in the third quarter of this year. The company also …See details»
APRILBIO
Welcome to Aprilbio. Intro; Management; History; Contact Us; COMPANY; Contact Us; Contact Us. Head Quarter. ADDRESS #602 Building B, Medical and Bioscience College, Gangwon …See details»
Aprilbio Co. Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
About AprilBio AprilBio Co., Ltd. is a biopharmaceutical company in South Korea founded in 2013. The company is specialized in development of specialized biologics and antibody drugs. The …See details»
AprilBio - Overview, News & Similar companies | ZoomInfo.com
AprilBio contact info: Phone number: (804) 330-3353 Website: www.aprilbio.com What does AprilBio do? AprilBio Co Ltd is a company that operates in the Biotechnology industry. It …See details»
AprilBio Co.,Ltd. (397030.KQ) Company Profile & Facts - Yahoo …
See the company profile for AprilBio Co.,Ltd. (397030.KQ) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Company AprilBio Co.,Ltd. - MarketScreener.com
Mar 30, 2022 Company AprilBio Co.,Ltd. Equities A397030 KR7397030008 Biotechnology & Medical Research End-of-day quote Korea S.E. Other stock markets. 2024-12-24 5-day …See details»
Aprilbio Co Ltd - VentureRadar
Aprilbio Co., Ltd. owns long-acting protein medicine platform technology utilizing human FAB antibody parts that makes unusual combination to serum albumin and EX-12 Helper Phage …See details»
AprilBio Co.,Ltd. Company Description - Stock Analysis
Oct 18, 2024 AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It …See details»
AprilBio Co. Ltd. - BioCentury Company Profiles - BCIQ
Nov 7, 2023 AprilBio Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
AprilBio Company Profile | Management and Employees List
Find contact information for AprilBio. Learn about their Internet Service Providers, Website Hosting & Internet-related Services, Telecommunications market share, competitors, and …See details»
AprilBio Company Profile 2025: Stock Performance
AprilBio General Information Description. AprilBio Co Ltd is a bio company is developing innovative biologis. It owns long acting protein medicine platform technology utilizing human FAB antobody parts that makes unusual …See details»
AprilBio Co., Ltd Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AprilBio Co., Ltd of Chuncheon, Gangwon. Get the latest business insights from Dun & Bradstreet.See details»
Organization: AprilBio - Cbonds.com
Organization: AprilBio Organization name. AprilBio Co., Ltd. Country name. Republic of Korea Country of registration. Republic of Korea. Industry. Pharmaceutical Preparation and …See details»
APRILBIO
Aprilbio Co., LTD has built intimate networks for cooperation with leading enterprises and academic institutions in and out of Korea Please email us at [email protected] for partnering …See details»
APB-ADC(Aprilbio) - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 APB-ADC(Aprilbio), Initially developed by Aprilbio Co. Ltd., Now, its global highest R&D status is Discovery, Therapeutic Areas: Neoplasms, Active Indication: Solid tumor, Active …See details»
AprilBio Co Ltd Overview - Salary.com
AprilBio Co Ltd Information BETA. Headquarters Address: 3024 Stony Point Rd, Richmond, Virginia. Phone Number: +1 8043303353. Revenue: $1 Million - $5 Million ... The trusted data …See details»
APRILBIO
AprilBio, APB-A1 "The composition patent granted in the U.S." 2023.10.05 AprilBio (CEO, Sang-hoon CHA) announced on the 5th of October that the compound patent of APB-A1 (Lu …See details»
AprilBio licenses out autoimmune disease to US firm for $475 mil.
Jun 21, 2024 Local analyst increase target price for AprilBio. Korea Investment & Securities raised the target price of AprilBio, stating that the company will turn a profit solely through …See details»